The Joint Corp. faces declining comparable sales and lower new patient acquisition, with clinic count projected to decrease in 2026 due to strategic portfolio reshaping limiting near-term growth.
The Joint Corp. faces declining comparable sales and lower new patient acquisition, with clinic count projected to decrease in 2026 due to strategic portfolio reshaping limiting near-term growth.
The Joint Corp. faces declining comparable sales and lower new patient acquisition, with clinic count projected to decrease in 2026 due to strategic portfolio reshaping limiting near-term growth.
